We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Studio Pictures Ltd is a UK-based film and TV production company founded by producers Adam Rolston and David Braithwaite in 2019. Specializing in creating high-quality British entertainment content, the company focuses on adapting books to screen and telling unique true-life stories that entertain and inspire both domestic and international audiences. With successful productions like "A Street Cat Named Bob," the company is building a strong brand and reputation in the industry. Studio Pictures has access to top creative talent and collaborates with major studios like Warner Bros, Sony Pictures, Lionsgate, and Studio Canal. The company is located at Twickenham Studios in Richmond, UK.
days to go: 17 investment: Withheld
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Erpingham House is the UK’s largest vegan restaurant whose aim is to make plant-based dining into the mainstream and provide delicious, healthy food and drinks to people. The company has earned nationwide recognition and, it has been listed in The Times top 20 vegetarian restaurants. It has also been featured in The Guardian and on channel 4’s “what Britain bought.” EH has served over 12,000 customers in its first year and, it has risen to over 20,000 followers on Instagram. The funds will be used to expand the brand & open a second site in Brighton.
days to go: Expired investment: £192,280
The Studio enable members to achieve results through sustainable, structured training. The Studio offer a whole range of sessions such as group classes, one-to-one personal training, spinning and yoga.   
days to go: Expired investment: £30,564
MenuLab helps food businesses track allergens in the food they serve to customers via a smartphone app. 
days to go: Expired investment: £1,989
Two Drifters Distillery (TDD) is one of the very few British distilleries that makes rum from raw ingredients, rather than importing and flavouring it. It has worked with Climeworks Direct Air Capture technology to remove CO2 from its products. The company's technique won admirers leading to a boost in sales. Since its launch in 2019, TDD converted existing equipment to increase capacity from 80 bottles per week to an estimated 1800 per week. It has also secured contracts from prominent entities including John Lewis (national and online), Exeter Chiefs Rum and Virgin Wines. The company has an active social media community with 10,000+ followers and also conducts weekly distillery tours that see full attendance from its customers. TDD has also received press coverage from media houses including The BBC, The Telegraph and The Independent. It will use the investment to grow its sales and showcase its product at retail outlets, and bring to the masses sustainably-made British products.

Pitch Rated

40%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £286,340
Drop Bear Beer Co. aims in disrupting and exciting the alcohol-free beer market. It is the only female-run alcohol-free craft beer company. Drop Bear Beer Co.'s May 2019 launch was a success as it experienced sales of 3000 units in one month. The company is a winner of the Wales Start-Up of the Year Awards 2019. With the proceeds, Drop Bear Beer Co. will finalise core range within 12 months, scale-up production, make range available in cans, and arrange a large brand-building campaign.
days to go: Expired investment: £172,570
Bringing an Italian tradition to the UK, the team at Miccone are raising funds to open their first permanent site in London. 22% of British Adults choose Italian food when eating out, so the team are bringing their experience from an Italian Miccone in Pavia to the streets of London.
days to go: Expired investment: £85,920
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph